Abstract
摘要
相似文献
1
Her accidental legacy.
Newsweek. 2003 Oct 13;142(15):64.
2
Comment: analysis of severe adverse events related to the use of mifepristone as an abortifacient.评论：米非司酮作为堕胎药使用相关严重不良事件的分析。
Ann Pharmacother. 2006 Apr;40(4):785-6; author reply 786. doi: 10.1345/aph.1G481c. Epub 2006 Mar 28.
3
Aligning mifepristone regulation with evidence: driving policy change using 15 years of excellent safety data.使米非司酮监管符合证据：利用15年的出色安全数据推动政策变革。
Contraception. 2015 Sep;92(3):179-81. doi: 10.1016/j.contraception.2015.06.016. Epub 2015 Jun 18.
4
Comment: analysis of severe adverse events related to the use of mifepristone as an abortifacient.
Ann Pharmacother. 2006 Jun;40(6):1215-6; author reply 1216-7. doi: 10.1345/aph.1G481d. Epub 2006 May 30.
5
Mifepristone for termination of early pregnancy.
FDA Consum. 2000 Nov-Dec;34(6):7.
6
Mifepristone label laws and trends in use: recent experiences in four US states.米非司酮标签法规及使用趋势：美国四个州的近期经验
Contraception. 2015 Sep;92(3):182-5. doi: 10.1016/j.contraception.2015.06.017. Epub 2015 Jun 23.
7
Fatal infections associated with mifepristone-induced abortion.
N Engl J Med. 2005 Dec 1;353(22):2317-8. doi: 10.1056/NEJMp058260.
8
The long, winding road of RU-486.
Newsweek. 2000 Oct 2;136(14):50.
9
The pill arrives.药丸到了。
Time. 2000 Oct 9;156(15):40-6, 49.
10
Thrombotic thrombocytopenic purpura secondary to mifepristone in a patient of medical termination in early pregnancy.米非司酮继发血栓性血小板减少性紫癜一例早期妊娠药物流产患者
Ann Hematol. 2007 May;86(5):385-6. doi: 10.1007/s00277-006-0237-7. Epub 2006 Dec 16.
Zotero 插件